IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial - Concepedia

Concepedia

Publication | Closed Access

IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial

596

Citations

27

References

2021

Year

Paul M. Ridker, Matt Devalaraja, Florian M.M. Baeres, Mads D.M. Engelmann, G. Kees Hovingh, Milana Ivkovic, Larry Lo, Douglas Kling, Pablo E. Pérgola, Dominic S. Raj,

InflammationAnti-inflammatoryCardiovascular DiseaseImmunologyClinical TrialsChronic InflammationPharmacologyPharmacotherapyHigh Atherosclerotic RiskMedicineAtherosclerosisRheumatoid ArthritisIl-6 Inhibition

References

	Year	Citations

Page 1

Page 1